with regard to the indication of bmt , the following factors were selected as significantly favorable : young age , in remission , no infection , complete hla-matched marrow donor , no previous radiation treatment of the brain or lung , fractionated tbi , low dose rate , platelet transfusion from anti-cmv antibody-negative donor .
C0006104
brain
C0876926
tbi